Literature DB >> 16680073

Age-dependent acceleration of ischemic injury in endothelial nitric oxide synthase-deficient mice: potential role of impaired VEGF receptor 2 expression.

Hu Sheng Qian1, Micheline Monterio de Resende, Christian Beausejour, Ling-Yuh Huw, Perry Liu, Gabor M Rubanyi, Katalin Kauser.   

Abstract

Morbidity and mortality of peripheral arterial occlusive disease significantly increases with age, often exhibiting more severe disease pathology and decreased treatment effectiveness. Therapeutic angiogenesis with angiogenic growth factors may represent a valuable treatment option for the severely ill, older adult patient population. Aging is considered an independent cardiovascular risk factor, but pathomechanistically it is not well understood. Diminished endothelial nitric oxide (EDNO) production has been considered as a major contributor to the aging process. To investigate the effect of age on postischemic revascularization independent of changes in EDNO, we used endothelial nitric oxide synthase-deficient (ecNOS-KO) mice. We found an age-dependent acceleration in ischemic injury following unilateral femoral artery ligation in these animals compared to C57BL/J6 mice. Postischemic revascularization, quantified by measuring von Willebrand factor expression, was significantly impaired, suggesting that factors other than progressive EDNO deterioration are also involved in the age-dependent severe disease phenotype. Ischemia led to an increase in the expression of vascular endothelial growth factor receptor-2, KDR, in younger ecNOS-KO; however, this increase in KDR expression was absent in the older animals. Lack of increased KDR expression may provide a mechanistic explanation for the severe ischemic injury and perhaps can be used as a clinical marker to identify severe, vascular endothelial growth factor refractory patient population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680073     DOI: 10.1097/01.fjc.0000211736.55583.5c

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

Review 1.  Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.

Authors:  Gabor M Rubanyi
Journal:  Mol Ther       Date:  2013-02-12       Impact factor: 11.454

2.  Attenuation of brain response to vascular endothelial growth factor-mediated angiogenesis and neurogenesis in aged mice.

Authors:  Peng Gao; Fanxia Shen; Rodney Allanigue Gabriel; David Law; Ethan Yibo Yang; Ethan Yang; Guo-Yuan Yang; William L Young; Hua Su
Journal:  Stroke       Date:  2009-09-10       Impact factor: 7.914

3.  Changes in growth factor expression in normal aging of the rat retina.

Authors:  Christopher P Smith; Jena J Steinle
Journal:  Exp Eye Res       Date:  2007-08-29       Impact factor: 3.467

Review 4.  Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications.

Authors:  Joshua K Meisner; Richard J Price
Journal:  Microcirculation       Date:  2010-11       Impact factor: 2.628

5.  Korean Red ginseng prevents endothelial senescence by downregulating the HO-1/NF-κB/miRNA-155-5p/eNOS pathway.

Authors:  Tae-Hoon Kim; Ji-Yoon Kim; Jieun Bae; Young-Mi Kim; Moo-Ho Won; Kwon-Soo Ha; Young-Guen Kwon; Young-Myeong Kim
Journal:  J Ginseng Res       Date:  2020-08-14       Impact factor: 6.060

6.  Urolithin A augments angiogenic pathways in skeletal muscle by bolstering NAD+ and SIRT1.

Authors:  Nandini Ghosh; Amitava Das; Nirupam Biswas; Surya Gnyawali; Kanhaiya Singh; Mahadeo Gorain; Carly Polcyn; Savita Khanna; Sashwati Roy; Chandan K Sen
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.